Skip to main content
. 2016 Jun 27;10(6):e0004806. doi: 10.1371/journal.pntd.0004806

Fig 1. Impact of anti-C. sinensis treatment on antiviral therapies in co-infected patients.

Fig 1

Elevated liver transaminases (including AST, ALT and TB) and HBV DNA copies in the plasma of co-infected patients were detected after receiving combination treatment ETV and PZQ or not. (A) AST and (B) ALT and (C) TB were measured in plasma. (D) HBV DNA levels were measured by RT-PCR. Symbols show individual measurements within the patient groups, and the graphs show the means ± SD. Asterisks indicate statistically significant differences between NONPZQ and PZQ groups, as measured by paired, two-tailed Student's t-test (*p <0.05, ** p <0.01)